Jury Orders AndroGel Maker AbbVie to Pay $3M After Judge Rejected $150M

Article 0 Comments A U.S. jury on Monday ordered AbbVie Inc. to pay more than $3 million to a man who claimed the company misrepresented the risks of its testosterone replacement drug AndroGel, causing him to suffer a heart attack, though the jury did not find AbbVie strictly liable. The […]